Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Gastric Cancer × pazopanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 31 Sarcoma 27 Neoplasm Metastasis 15 Ovarian Neoplasms 9 Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 6 Lung Neoplasms 5 Kidney Neoplasms 5 Thyroid Neoplasms 4 Recurrence 4 Melanoma 4 Liposarcoma 4 Leiomyosarcoma 4 Hemangiosarcoma 4 Urinary Bladder Neoplasms 3 Solid Tumors 3 Pancreatic Neoplasms 3 Neurofibrosarcoma 3 Glioblastoma 3 Gastrointestinal Stromal Tumors 3 Chondrosarcoma, Extraskeletal Myxoid 3 Advanced Cancers 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Fibrous Tumors 2 Small Cell Lung Carcinoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdomyosarcoma 2

Interventions

apatinib 7 Paclitaxel 7 Capecitabine 7 Oxaliplatin 6 Cisplatin 5 camrelizumab 4 S 1 (combination) 3 Fluorouracil 3 130-nm albumin-bound paclitaxel 3 Leucovorin 2 Drug Therapy 2 Docetaxel 2 trifluridine tipiracil drug combination 1 titanium silicide 1 tipiracil 1 raltitrexed 1 pazopanib 1 olaparib 1 lobaplatin 1 ezogabine 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 Trifluridine 1 Sunitinib 1 Ramucirumab 1 Metabolic Networks and Pathways 1 Irinotecan 1 HMPL-013 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01503372 2019-02-12

PaFLO

Charite University, Berlin, Germany

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡